Mapping of HLA class I binding motifs in forty-four fusion proteins involved in human cancers

Clinical Cancer Research

Volumn 3, Issue 5, 1997, Pages 675-683

  Gambacorti Passerini, Carlo ^a   Bertazzoli, Carla ^a   Dermime, Said ^b   Scardino, Antonio ^c   Schendel, Dolores ^d   Parmiani, Giorgio ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HYBRID PROTEIN;

ANTIGEN SPECIFICITY; ARTICLE; BINDING AFFINITY; GENE MAPPING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOASSAY; LEUKEMIA; PRIORITY JOURNAL; PROMYELOCYTE; PROTEIN ANALYSIS;

AMINO ACID SEQUENCE; BINDING SITES; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; MOLECULAR SEQUENCE DATA; NEOPLASMS; ONCOGENE PROTEINS, FUSION; PEPTIDE FRAGMENTS; PEPTIDE LIBRARY; TRANSLOCATION, GENETIC;

EID: 0030974422     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Rabbitts, T. H. Chromosomal translocations in human cancer Nature (Lond.), 372: 143-149, 1994.
2. Grignani, F., Fagioli, M., Alcalay, M., Longo, L., Pandolfi, P. P., Donti, E., Biondi A., Lo Coco, F., Grignani, F., and Pelicci, P. G. Acute promyelocytic leukaemia: from genetics to treatment. Blood. 83: 10-25, 1994.
3. BCR/ABL gene of the Philadelphia chromosome. Science (Washington DC), 247: 824-830, 1990.
4. Heisterkamp, N., Jenster, G., ten Hoeve, J., Zovich, D., Pattengale, P. K., and Groffen, J. Acute leukemia in BCR/ABL transgenic mice. Nature (Lond.), 344: 251-253, 1990.
5. INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma. Science (Washington DC), 269: 1281-1284, 1995.
6. Schumacher, T., De Bruijn, M. L. H., Vernie, L. N., Kast, W. M., Melief, C. J. M., Neefjes, J. J., and Ploegh, H. L. Peptide selection by MHC class I molecules. Nature (Lond.), 350: 703-706, 1991.
7. Rudensky, A. Y., Preston-Hurlburt, P., Hong, S-C., Barlow, A., and Janeway, C. A. Sequence analysis of peptides bound to MHC class II molecules. Nature (Lond.), 353: 622-627, 1991.
8. Rötzschke, O., Falk, K., Deres, K., Schild, H., Norda, M., Metzger, J., Jung, G., and Rammensee, H. G. Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells. Nature (Lond.), 348: 252-257, 1990.
9. Rammensee, H. G., Friede, T., and Stefanovic, S. MHC ligands and peptide motifs: first listing. Immunogenetics, 41: 178-228, 1995.
10. Townsend, A., Ohlen, C., Rogers, M., Edwards, J., Mukherjee, S., and Bastin, J. Source of unique tumor antigens. Nature (Lond.), 371: 662, 1994.
11. Chen. W., Peace, D. J., Rovira, D. K., You, S-G., and Cheever, M. A. T-cell immunity to the joining region of p210BCR-ABL protein. Proc. Natl. Acad. Sci. USA, 89: 1468-1472, 1992.
12. Gambacorti-Passerini, C., Grignani, F., Arienti, F., Pandolfi, P. P., Pelicci, P. G., and Parmiani, G. Human CD4 lymphocytes specifically recognize a peptide representing the fusion region of the hybrid protein pml/RARa present in acute promyelocytic leukemia cells. Blood, 81: 1369-1375, 1993.
13. MHCPEP: a database of MHC-binding peptides. Nucleic Acids Res., 22: 3663-3665, 1994.
14. Kast, W. M., Brandt, M. P., Sidney, J., Drijfhout, J-W., Kubo, R. T., Grey, H. M., Melief, C. J. M., and Sette, A. Role of HLA-A motifs in identification of potential CTL epitopes in human papillomavirus type 16 E6 and E7 proteins. J. Immunol., 152: 3904-3912, 1994.
15. Baur, M. P., et al. Population analysis on the basis of deduced haplotypes from random families. In: E. D. Albert, M. P. Baur, and W. R. Mayr (eds.), Histocompatibility Testing. Berlin: Springer-Verlag, 1984.
16. Salter, R. D., and Cresswell, P. Impaired assembly and transport of HLA-A and B antigens mutants TxB cell hybrid. EMBO J., 5: 943-949, 1986.
17. Steinle, A., and Schendel, D. J. HLA class I alleles of LCL 721 and 174xCEM.T2(T2). Tissue Antigens, 44: 268-270, 1994.
18. De la Salle, H., Hanau, D., Flicker, D., Urlacher, A., Kelly, A., Salamero, J., Powis, S. H., Donato, L., Bausinger, H., Laforet, M., Jeras, M., Spehner, D., Bieber, T., Falkenrodt, A., Cazenave, J. P., Trowsdale, T., and Tongio, M. M. Homozygous human TAP peptide transporter mutation in HLA class I deficiency. Science (Washington DC), 265: 237-241, 1994.
19. Falk, C. S., Steinle, A., and Schendel, D. J. Expression of HLA-C molecules confers target cell resistance to some non-major histocompatibility complex-restricted T cells in a manner analogous to allospecific natural killer cells. J. Exp. Med., 182: 1005-1018, 1995.
20. Neijman, H. W., Houbiers, J. G. A., Vierboom, M. P., Van der Burg, S. H., Drijfhout, J-W., D'Amaro, J., Kenemans, P., Melief, C. J. M., and Kast, W. M. Identification of peptide sequences that potentially trigger HLA-A2.1-restricted cytotoxic T lymphocytes. Eur. J. Immunol., 23: 1215-1219, 1993.
21. Rupper, J., Sidney, J., Celis, E., Kubo, R. T., Grey, H. M., and Sette, A. Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules. Cell, 74: 929-937, 1993.
22. Heisterkamp, N., Stam, K., Groffen, J., de Klein, A., and Groffen, G. Structural organization of the bcr gene and its role in the Ph (1) translocation. Nature (Lond.), 315: 758-761, 1985.
23. Yamamoto, K., Seto, M., Komatsu, H., Iida, S., Akao, Y., Kojima, S., Kodera, Y., Nakazawa, S., Ariyoshi, Y., Takahashi, T., and Ueda, R. Two distinct portions of LTG19/ENL at 19p13 are involved in (11;19) leukemia. Oncogene, 8: 2617-2625, 1993.
24. Nakamura, T., Alder, H., Gu, Y., Prasad, R., Canaani, O., Kamada, N., Gale, R. P., Lange, B., Crist, W. M., Nowell, P. C., Croce, C. M., and Canaani, E. Genes on chromosome 4, 9, and 19 involved in 11q23 abnormalities in acute leukemia share sequence homology and/or common motifs. Proc. Natl. Acad. Sci. USA, 90: 4631-4635, 1993.
25. Bocchia, M., Wentworth, P. A., Southwood, S., Sidney, J., McGraw, K., Scheinberg, D. A., and Sette, A. Specific binding of leukemia oncogene fusion protein peptides to HLA class I molecules. Blood, 85: 2680-2684, 1995.
26. Bocchia, M., Korontsvit, T., Xu, Q., Mackinnon, S., Yang, S. Y., Sette, A., and Scheinberg, D. A. Specific human cellular immunity to BCR-ABL oncogene derived peptides. Blood, 87: 3587-3592, 1996.
27. Dermime, S., Molldren, J., Parker, K. C., Jiang, Y. Z., Mavroudis, D., Hensel, N., Couriel, D., Mahoney, M., Coligan, J. E., and Barrett, A. J. Human CD8+ T lymphocytes recognize the fusion region of BCR-ABL hybrid protein present in chronic myelogenous leukemia. Thirty-seventh meeting of the American Society of Hematology, #620. Seattle, December 1-5, 1995.
28. Wiedenfeld, E. A., Fernandez-Vina, M., Berzofsky, J. A., and Carbone, D. P. Evidence for selection against human lung cancers bearing p53 missense mutations which occur within the HLA A*0201 peptide consensus motif. Cancer Res., 54: 1175-1177, 1994.
29. Nisticò, P., Mottolese, M., Benevolo, M., Mammi, C., Del Bello, C., Botti, C., Ventura, I., and Natali, P. G. Influence of HLA.A2 phenotype on the Her-2 overexpression in breast cancer patients. Proc. Am. Assoc. Cancer Res., 37: 3349, 1996.
30. Joventino, L., Stock, W., Lane, N. J., Daly, K. M., Mick, K., Le Beau, M. M., and Larson, R. A. Certain HLA antigens are associated with specific morphologic and cytogenetic subsets of acute myeloid leukemia. Leukemia (Baltimore), 9: 433-439, 1995.
31. Pierotti, M. A., Bongarzone, I., Borrello, M. G., Greco, A., Pilotti, S., and Sozzi, G. Cytogenetic and molecular genetics of the carcinomas arising from the thyroid epithelial follicular cells. Genes Chromosomes Cancer, 16: 1-14, 1996.
32. Chen, Z., Brand, N. J., Chen, A., Chen, S-J., Tong, J-H., Wang, S-Y., Waxman, S., and Zelent, A. Fusion between a novel Krüppel-like zinc finger gene and the retinoic acid receptor-a locus due to a variant t(11;17) translocation associated with acute promyelocytic leukemia. EMBO J., 12: 1161-1167, 1993.
33. Clark, S., McLaughlin, J., Timmons, M., Pendergast, A. M., Ben-Neriah, Y., Dow, L. W., Crist, W., Rovera, G., Smith, S. D., and Witte, O. N. Expression of a distinctive BCR-ABL oncogene in PH (1)-positive acute lymphoblastic leukemia (ALL). Science (Washington DC), 239: 775-777, 1988.
34. Nourse, J., Mellentin, J. D., Galili, N., Wilkinson, J., Stanbridge, E., Smith, S., and Cleary, M. L. Chromosomal translocation t(1;19) results in synthesis of a homeobox fusion mRNA that codes for a potential chimeric transcription factor. Cell, 60: 535-545, 1990.
35. Inaba, T., Roberts, W. M., Shapiro, L. H., Jolly, K. W., Raimondi, S. C., Smith, S. D., and Look, T. A. Fusion of the leucine zipper gene HLF to the E2A gene in human acute B-lineage leukemia. Science (Washington DC), 257: 531-534, 1992.
36. Gu, Y., Nakamura, T., Alder, H., Prasad, R., Canaani, O., Cimino, G., Croce, C. M., and Canaani, E. The t(4;11) chromosome translocation of human acute leukemias fuses the ALL-1 gene, related to Drosophila trithorax, to the AF-4 gene. Cell, 71: 701-708, 1992.
37. Downing, J. R. The der(11)-encoded MLL/AF-4 fusion transcript is consistently detected in the t(4;11)(q21;q23)-containing acute lymphoblastic leukemia. Blood. 83: 330-335, 1994.
38. Prasad, R., Gu, Y., Alder, H., Nakamura, T., Canaani, O., Saito, H., Huebner, K., Gale, R. P., Nowell, P. C., Kuriyama, K., Miyazaki, Y., Croce, C. M., and Canaani, E. Cloning of the ALL-1 fusion partner, the AF-6 gene, involved in acute myeloid leukemias with the t(6:11) chromosome translocation. Cancer Res., 53: 5624-5628, 1993.
39. Prasad, R., Leshkowits, D., Gu, Y., Alder, H., Nakamura, T., Saito, H., Huebner, K., Berger, R., Croce, C. M., and Canaani, E. Leucine-zipper dimerization motif encoded by the AF17 gene fused to ALL-1 (MLL) in acute leukemia. Proc. Natl. Acad. Sci. USA, 91: 8107-8111, 1994.
40. Thirman, M. J., Levitan, D. A., Kobayashi, H., Celeste Simon, M., and Rowley, J. Cloning of ELL, a gene that fuses to MLL in a t(11; 19)(q23;p13.1) in acute myeloid leukemia. Proc. Natl. Acad. Sci. USA. 91: 12110-12114, 1994.
41. Zucman, J., Melot, T., Desmaze, C., Ghysdael, J., Plougastel, B., Peter, M., Zucker, J. M., Triche, T. J., Sheer, D., Turc-Carel, C., Ambros, P., Combaret, V., Lenoir, G., Aurias, A., Thomas, G., and Delattre, O. Combinatorial generation of variable fusion proteins in the Ewing family of tumours. EMBO J., 12: 4481-4487, 1993.
42. Zucman, J., Delattre, O., Desmaze, C., Epstein, A. L., Stenman, G., Speleman, F., Fletchers, C. D. M., Aurias, A., and Thomas, G. EWS and ATF-1 gene fusion induced by t(12;22) translocation in malignant melanoma of soft parts. Nat. Genet., 4: 341-344, 1993.
43. Myoshi, H., Kozu, T., Shimizu, K., Enomoto, K., Maseki, N., Kaneko, Y., Kamada, N., and Ohki, N. The t(8;21) translocation in acute myeloid leukemia results in production of an AML1-MTG8 fusion transcript. EMBO J., 12: 2715-2721, 1993.
44. Mitani, K., Ogawa, S., Tanaka, T., Miyoshi, H., Kurokawa, M., Mano, H., Yazaki, Y., Ohki, M., and Hirai, H. Generation of the AML1-EVI-1 fusion gene in the t(3;21)(q26:q22) causes blastic crisis in chronic myelocytic leukemia. EMBO J., 13: 504-510, 1994.
45. Golub, T. R., Baker, G. F., Lovett, M., and Gilliland, D. G. Fusion of PDGF receptor β to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell, 77: 307-316, 1994.
46. Liu, P., Tarle, S. A., Hajra, A., Claxton, D. F., Marlton, P., Freedman, M., Siciliano, M. J., and Collins, F. S. Fusion between transcription factor CBFβ/PEBP2β and a myosin heavy chain in acute myeloid leukemia. Science (Washington DC), 261: 1041-1044. 1993.
47. von Linderen, M., Fornerod, M., van Baal, S., Jaegle, M., de Wit, T., Buijs, A., and Glosveld, G. The translocation (6;9) associated with a specific subtype of acute myeloid leukemia results in the fusion of two genes, dek and can, and the expression of a chimeric leukemia-specific dek-can mRNA. Mol. Cell. Biol., 12: 1687-1697, 1992.
48. Ichikawa, H., Shimizu, K., Hayashi, Y., and Ohki, M. An RNA-binding protein gene, TLS/FUS, is fused to ERG in human myeloid leukemia with t(16;21) chromosomal translocation. Cancer Res., 54: 2865-2868, 1994.
49. Morris, S. W., Kirstein, M. N., Valentine, M. B., Dittmer, K. G., Shapiro, D. N., Saltman, D. L., and Look, A. T. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science (Washington DC), 263: 1281-1284, 1994.
50. Laabi, Y., Gras, M. P., Carbonnel, F., Brouet, J. C., Berger, R., Larsen, C. J., and Tsapis, A. A new gene, BCM, on chromosome 16 is fused to the interleukin 2 gene by a t(4;16)(q26;p13) translocation in a malignant T cell lymphoma. EMBO J., 11: 3897-3904, 1992.
51. Lu, D., Thompson, J. D., Gorski, G. K., Rice, N. R., Mayer, M. G., and Yunis, J. J. Alterations at the rel locus in human lymphoma. Oncogene, 6: 1235-1241, 1991.
52. Shapiro, D. N., Sublett, J. E., Li, B., Downing, J. R., and Naeve, C. W. Fusion of PAX3 to a member of the forkhead family of transcription factors in human alveolar rhabdomyosarcoma. Cancer Res., 53: 5108-5112, 1993.
53. Crozat, A., Aman, P., Mandahal, N., and Ron, D. Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma. Nature (Lond.), 363: 640-644, 1993.
54. Rabbitts, T. H., Foster, A., Larson, R., and Nathan, P. Fusion of the dominant negative transcription regulator CHOP with a novel gene FUS by translocation t(12;16) in malignant liposarcoma. Nat. Genet., 4: 175-180, 1993.